Skip to main content
NCBI home page
Journal of Medical Genetics logoLink to Journal of Medical Genetics
. 1995 Mar;32(3):170–173. doi: 10.1136/jmg.32.3.170

A rapid, non-radioactive screening test for fragile X mutations at the FRAXA and FRAXE loci.

Q Wang 1, E Green 1, M Bobrow 1, C G Mathew 1
PMCID: PMC1050311  PMID: 7783163

Abstract

Screening of referrals for the mutations associated with the fragile X syndrome constitutes a significant workload in many genetics laboratories. Since the great majority of these referrals will be negative, there is a need for a rapid and inexpensive screening test. We have developed an assay which allows simultaneous amplification of the triplet repeat sequences at the FRAXA and FRAXE loci by polymerase chain reaction, and detection of the products on non-denaturing gels stained with ethidium bromide. Alleles of normal size are detected, leaving a small minority of samples to be tested by Southern blotting. A PCR based assay for detection of methylation at the CpG island upstream of the FMR-1 gene has also been devised.

Full text

PDF
170

Images in this article

172Image
on p.172
173Image
on p.173

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brown W. T., Houck G. E., Jr, Jeziorowska A., Levinson F. N., Ding X., Dobkin C., Zhong N., Henderson J., Brooks S. S., Jenkins E. C. Rapid fragile X carrier screening and prenatal diagnosis using a nonradioactive PCR test. JAMA. 1993 Oct 6;270(13):1569–1575. [PubMed] [Google Scholar]
  2. Erlich H. A., Gelfand D., Sninsky J. J. Recent advances in the polymerase chain reaction. Science. 1991 Jun 21;252(5013):1643–1651. doi: 10.1126/science.2047872. [DOI] [PubMed] [Google Scholar]
  3. Flynn G. A., Hirst M. C., Knight S. J., Macpherson J. N., Barber J. C., Flannery A. V., Davies K. E., Buckle V. J. Identification of the FRAXE fragile site in two families ascertained for X linked mental retardation. J Med Genet. 1993 Feb;30(2):97–100. doi: 10.1136/jmg.30.2.97. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Fu Y. H., Kuhl D. P., Pizzuti A., Pieretti M., Sutcliffe J. S., Richards S., Verkerk A. J., Holden J. J., Fenwick R. G., Jr, Warren S. T. Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell. 1991 Dec 20;67(6):1047–1058. doi: 10.1016/0092-8674(91)90283-5. [DOI] [PubMed] [Google Scholar]
  5. Gustavson K. H., Blomquist H. K., Holmgren G. Prevalence of the fragile-X syndrome in mentally retarded boys in a Swedish county. Am J Med Genet. 1986 Jan-Feb;23(1-2):581–587. doi: 10.1002/ajmg.1320230152. [DOI] [PubMed] [Google Scholar]
  6. Knight S. J., Flannery A. V., Hirst M. C., Campbell L., Christodoulou Z., Phelps S. R., Pointon J., Middleton-Price H. R., Barnicoat A., Pembrey M. E. Trinucleotide repeat amplification and hypermethylation of a CpG island in FRAXE mental retardation. Cell. 1993 Jul 16;74(1):127–134. doi: 10.1016/0092-8674(93)90300-f. [DOI] [PubMed] [Google Scholar]
  7. Kremer E. J., Pritchard M., Lynch M., Yu S., Holman K., Baker E., Warren S. T., Schlessinger D., Sutherland G. R., Richards R. I. Mapping of DNA instability at the fragile X to a trinucleotide repeat sequence p(CCG)n. Science. 1991 Jun 21;252(5013):1711–1714. doi: 10.1126/science.1675488. [DOI] [PubMed] [Google Scholar]
  8. Latimer L. J., Lee J. S. Ethidium bromide does not fluoresce when intercalated adjacent to 7-deazaguanine in duplex DNA. J Biol Chem. 1991 Jul 25;266(21):13849–13851. [PubMed] [Google Scholar]
  9. Pieretti M., Zhang F. P., Fu Y. H., Warren S. T., Oostra B. A., Caskey C. T., Nelson D. L. Absence of expression of the FMR-1 gene in fragile X syndrome. Cell. 1991 Aug 23;66(4):817–822. doi: 10.1016/0092-8674(91)90125-i. [DOI] [PubMed] [Google Scholar]
  10. Sutherland G. R., Baker E. Characterisation of a new rare fragile site easily confused with the fragile X. Hum Mol Genet. 1992 May;1(2):111–113. doi: 10.1093/hmg/1.2.111. [DOI] [PubMed] [Google Scholar]
  11. Sutherland G. R., Brown W. T., Hagerman R., Jenkins E., Lubs H., Mandel J. L., Nelson D., Neri G., Partington M. W., Richards R. I. Sixth international workshop on the fragile X and X-linked mental retardation. Am J Med Genet. 1994 Jul 15;51(4):281–293. doi: 10.1002/ajmg.1320510402. [DOI] [PubMed] [Google Scholar]
  12. Verkerk A. J., Pieretti M., Sutcliffe J. S., Fu Y. H., Kuhl D. P., Pizzuti A., Reiner O., Richards S., Victoria M. F., Zhang F. P. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell. 1991 May 31;65(5):905–914. doi: 10.1016/0092-8674(91)90397-h. [DOI] [PubMed] [Google Scholar]
  13. Wang Q., Green E., Barnicoat A., Garrett D., Mullarkey M., Bobrow M., Mathew C. G. Cytogenetic versus DNA diagnosis in routine referrals for fragile X syndrome. Lancet. 1993 Oct 23;342(8878):1025–1026. doi: 10.1016/0140-6736(93)92882-t. [DOI] [PubMed] [Google Scholar]
  14. Webb T. P., Bundey S. E., Thake A. I., Todd J. Population incidence and segregation ratios in the Martin-Bell syndrome. Am J Med Genet. 1986 Jan-Feb;23(1-2):573–580. doi: 10.1002/ajmg.1320230151. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Medical Genetics are provided here courtesy of BMJ Publishing Group

RESOURCES